Prospective multicenter clinical trial of Uretex Sup for surgical treatment of stress urinary incontinence.
OBJECTIVE
To evaluate in a prospective multicenter study the efficacy and safety of the suburethral support Uretex (Sofradim, Trevoux, France) delivered by a suprapubic approach in the treatment of female stress urinary incontinence.


METHODS
Between March 2002 and March 2003, 57 patients were treated for stress urinary incontinence with Uretex. Preoperative evaluation included urodynamic examination and questionnaires (symptoms and quality of life, Contilife). Forty patients had pure stress urinary incontinence and 17 mixed urinary incontinence. No associated procedure was performed. The objective cure rate was evaluated by clinical examination and pad-test, and the subjective cure rate was assessed through questionnaires at 1, 3 and 12 months.


RESULTS
The mean follow-up was 13 months (range 11-24 months). During follow up, chronic urinary retention requiring a tape section occurred in one patient, and in another patient a delay of vaginal healing was followed by a sling exposure and resection at 4 months. No infection or urethral erosion was reported. The objective cure rate was 96.2%, and the subjective cure rate was 79.2%; four patients reported low leakage on stress and nine patients complained of urge incontinence (four de novo and five persistent).


CONCLUSIONS
The suprapubic Uretex Sup procedure is a safe and effective treatment for women with stress urinary incontinence.
Cortesse
Ariane
A
Urology Department, St Louis Hospital, Assistance Publique-Hôpitaux de Paris, 1 Avenue Vellefaux, 75010 Paris, France. ariane.cortesse@sls.aphp.fr
Jacquetin
Bernard
B
Grise
Philippe
P
Le Normand
Loïc
L
Richard
François
F
Haab
François
F
D004867:Equipment Design; D005260:Female; D006801:Humans; D011446:Prospective Studies; D053825:Suburethral Slings; D014550:Urinary Incontinence, Stress / Q000601:surgery*; D013520:Urologic Surgical Procedures / Q000295:instrumentation